By: Adam Feuerstein | 03/28/14 - 04:16 PM EDTBiotech stocks continue to melt down. I know, broken record, but like a car wreck, it's hard not to look.
Warning: The following chart contains violent images not suitable for all investors.
Biotech stocks are no longer outperforming the broader market.
Our desk has been getting a lot of questions regarding inflows/outflows in Healthcare & Biotech ETFs. To put things into perspective: Healthcare ETFs saw $5 billion of inflows through March 19th. Since then, they've seen $1 billion of outflows in the sector (20% of YTD inflows.) Biotech ETFs in particular saw $1.3 billion inflows through March 19th and have had $380mm outflows over the past week (30% of YTD inflows.) US-listed ETFs have had $13 billion total inflows YTD. Through March 19th, about 40% of these inflows had been into health-care related ETFs.
08/21/14 - 10:23 AM EDT
08/14/14 - 10:20 AM EDT
08/13/14 - 12:04 PM EDT
08/12/14 - 05:11 PM EDT
08/12/14 - 07:17 AM EDT
08/22/14 - 08:50 AM EDT
08/21/14 - 11:12 AM EDT
08/21/14 - 09:53 AM EDT
08/20/14 - 10:17 AM EDT
08/20/14 - 09:50 AM EDT
David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Access the tool that DOMINATES the Russell 2000 and the S&P 500.